Changchun High-Tech Industry (Group) Co., Ltd. (SZSE: 000661)
Health Care · Pharmaceuticals · CN
CN¥76.11
-4.26% today · -27.3% 1Y
Changchun High-Tech Industry (Group) Co., Ltd. (SZSE: 000661) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.55B and employs 11,547 people.
Over the last twelve months the share price has lost 27.3%, trading between 61.09 and 141.77.
Tweenvest scores Changchun High-Tech Industry (Group) Co., Ltd. across four factors: quality 71/100, value 52/100, growth 22/100, dividend 35/100. Its strongest factor is quality.
000661 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.55B
- Revenue (TTM)
- $1.62B
- P/E
- —
- EPS
- -0.89
- Dividend yield
- 0.20%
- Beta (5Y)
- 0.32
- 52-week high
- CN¥141.77
- 52-week low
- CN¥61.09
- Avg volume (3M)
- —
- Shares outstanding
- 401.71M
- Employees
- 11,547
- Next earnings
- —
About Changchun High-Tech Industry (Group) Co., Ltd.
Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Additionally, the company diversifies its activities into property development, real estate management, and leasing services. Founded in Changchun, China, in 1993, this enterprise was previously known as Changchun High & New Technology Industry (Group) Inc.
- ISIN
- CNE0000007J8
- Founded
- 1993
- Listed since
- Dec 18, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.